Clinical Lab Molecular Diagnostics Test using QX200 ddPCR Instr.

The contract involves procuring Clinical Lab Molecular Diagnostics Testing services using the QX200 ddPCR Instrument. It is a presolicitation notice issued by the National Institutes of Health, part of the Department of Health and Human Services, targeting small businesses exclusively, as indicated by the Total Small Business Set-Aside designation under FAR 19.5. The solicitation number is 75N98026Q00356, and the relevant NAICS code is 334516, which pertains to measuring, analyzing, and controlling instrument manufacturing. The contract performance location is Bethesda, Maryland, where the requesting office is also based, with a response deadline set for May 24, 2026. Interested parties can direct questions or correspond with the primary point of contact, Roshonna Davis, via the provided NIH email. This opportunity reflects the agency's focus on specialized molecular diagnostic services, leveraging advanced droplet digital PCR technology, and supports small business participation in federal contracting.